Advertisement
Advertisement

LVTX

LVTX logo

LAVA Therapeutics NV

1.01
USD
-0.02
-1.94%
Dec 23, 10:02 UTC -5
Open

LAVA Therapeutics NV Profile

About

LAVA Therapeutics B.V. is a biotechnology company. It focuses on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy. LAVA Therapeutics B.V. is based in UTRECHT, The Netherlands.

Info & Links

CEO

Stephen Hurly

Headquarters

YALELAAN 62
UTRECHT, P7 3584 CM, NETHERLANDS

Auditor

PricewaterhouseCoopers Accountants N.V.

Share holders

--

Employees

35

LAVA Therapeutics NV Statistics

Valuation Measures

Market Capitalization2

--

Enterprise Value

--

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.29

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

39.09%

Operating Margin(ttm)

-228.02%

Profit Margin(ttm)

-462.18%

Return on Equity(ttm)

-62.22%

Return on Invested Capital(ttm)

-69.94%

Return on Assets(ttm)

-29.37%

Income Statement

Revenue(ttm)

7.34M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

7.19M

EBITDA(ttm)3

-29.70M

Net Income Available to Common(ttm)

-27.64M

Diluted EPS(ttm)

-1.03

Share Statistics

Beta (5Y Monthly)

0.43

52-Week Change

-34.42%

S&P 500 52-Week Change

24.03%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

0.79%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

78.88M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

6.29M

Total Debt/Equity(mrq)

19.06%

Current Ratio(mrq)

5.36%

Quick Ratio(mrq)

5.36%

Book Value Per Share(mrq)

1.25

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.68

Free Cash Flow(ytd)

-18.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement